Bascom Palmer Eye Institute invites you to join us in February 2025 for our 22nd annual angiogenesis meeting. This unique and exciting symposium entitled Angiogenesis, Exudation, and Degeneration 2025 will be held virtually on February 8, 2025. The program will feature an exceptional group of basic scientists, clinician scientists, and healthcare experts, all focused on understanding and treating neovascular, exudative, and degenerative diseases of the eye. The program will highlight the revolutionary therapies now in development and clinical practice for the management of non-exudative AMD, exudative AMD, diabetic retinopathy with and without macular edema, retinopathy of prematurity, and inherited retinal degenerations with a special emphasis on the present and future impact of these therapies on clinical practices.
COURSE DESCRIPTION
Angiogenesis 2025 follows the tradition of excellence established by Bascom Palmer’s widely acclaimed Angiogenesis programs between 2004 and 2024. Designed for retina specialists, general ophthalmologists and researchers, the current program will review the latest in imaging, translational research, and clinical trials with an emphasis on how these results will impact clinical ophthalmology. We will emphasize investigator-initiated research and recently completed clinical trials focused on the diagnosis and treatment of a wide range of retinal diseases with special emphasis on age-related macular degeneration, diabetic retinopathy, and retinal vascular diseases.
For more information, email bpeicme@med.miami.edu.
Contact Bascom Palmer Eye Institute Continuing Medical Education.